ERBB2 and neoplasm: When stratified by tumor receptor subtype, the proportion of nodal conversion from cN+ status to ypN0 status was 30.6% in HR+/HER2−, 66.7% in triple-negative, and 72.7% in HER2+ lobular cases (Fig. 4b).